Drug Profile
Monoclonal antibody MOC-31-In-111
Alternative Names: 111-In-DTPA-MOC-31Latest Information Update: 19 Sep 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Antibody-dependent cell cytotoxicity; Epithelial cell adhesion molecule inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 19 Sep 2001 No-Development-Reported for Cancer in Netherlands (IV-injection)
- 15 May 1997 New profile
- 15 May 1997 Investigation in Cancer in Netherlands (IV-injection)